Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chaiqin Pediatric Antipyretic Suppository in Acute Upper Respiratory Infection Fever
CTR20132866Phase 2Active
- Sponsor
- Anhui Institute of Pharmaceutical Research
- Start
- Jul 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chaiqin pediatric antipyretic suppository in upper respiratory infection (URI), sponsored by Anhui Institute of Pharmaceutical Research. Started Jul 2014; status: active.
02
Drugs
chaiqin pediatric antipyretic suppository
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20132866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132866.